839 Response and Healthcare Resource Utilization in Inflammatory Bowel Disease Patients Treated With Either Infliximab or Vedolizumab
2019 ◽
Vol 114
(1)
◽
pp. S485-S485
2020 ◽
Vol 115
(1)
◽
pp. S346-S347
2019 ◽
Vol 54
(6)
◽
pp. 726-732
2021 ◽
Vol 116
(1)
◽
pp. S414-S416
2020 ◽
Vol 115
(1)
◽
pp. S434-S434
2017 ◽
Vol 11
(suppl_1)
◽
pp. S262-S263
◽
2018 ◽
Vol 113
(Supplement)
◽
pp. S351